Not applicableStudy completedNCT06090929What this trial is testingSTN-DBS and the Risk of SialorrheaWho this might be right forParkinson Disease Qilu Hospital of Shandong University 234
Not applicableUnknownNCT06035913What this trial is testingMid-and Long-term Efficacy of Ergot Alkaloids in the Treatment of Salivation in Patients With Parkinson's Disease.Who this might be right forMain Heading (Descriptor) Terms Nanjing First Hospital, Nanjing Medical University 80
Testing effectiveness (Phase 2)Study completedNCT01844648What this trial is testingStudy of the Safety and Efficacy of Tropicamide Thin Films to Reduce Hypersalivation in Parkinson's PatientsWho this might be right forSialorrhea (Excessive Drooling) NeuroHealing Pharmaceuticals Inc. 30
Not applicableActive Not RecruitingNCT07588191What this trial is testingEffects of Transcutaneous Vagus Nerve Stimulation in Parkinson´s DiseaseWho this might be right forTranscutaneous Vagal Nerve Stimulation (tVNS)Parkinson Disease (PD) Universidade da Coruña 46
Testing effectiveness (Phase 2)WithdrawnNCT01565395What this trial is testingIncobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)Who this might be right forParkinson DiseaseAmyotrophic Lateral Sclerosis Beth Israel Deaconess Medical Center
Testing effectiveness (Phase 2)Study completedNCT00296946What this trial is testingIpratropium Spray for Drooling Saliva in Parkinson's DiseaseWho this might be right forParkinson's Disease University Health Network, Toronto 20
Testing effectiveness (Phase 2)Study completedNCT00761137What this trial is testingSafety and Efficacy Study of NH004 Films for Relief of Sialorrhea Symptoms in Parkinson's Disease PatientsWho this might be right forSialorrhea Secondary to Parkinson's Disease NeuroHealing Pharmaceuticals Inc. 19
Testing effectiveness (Phase 2)Study completedNCT00515437What this trial is testingA Multi-Center Study of MYOBLOC for the Treatment of Sialorrhea in Parkinson's Disease PatientsWho this might be right forDrooling Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC 54
Testing effectiveness (Phase 2)UnknownNCT02382198What this trial is testingStudy of Glycopyrrolate for Moderate-to-severe Sialorrhea in Parkinson's DiseaseWho this might be right forSialorrheaParkinson's Disease Ottawa Hospital Research Institute 28
Testing effectiveness (Phase 2)Study completedNCT01370811What this trial is testingA Relative Efficacy and Safety Study of OC Oral Solution for Sialorrhoea in Patients With Parkinson's DiseaseWho this might be right forSialorrhoea Orient Pharma Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT01653132What this trial is testingIncobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/ParkinsonismWho this might be right forSialorrhea Beth Israel Deaconess Medical Center 10
Large-scale testing (Phase 3)Study completedNCT02091739What this trial is testingClinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological ConditionsWho this might be right forChronic Troublesome SialorrheaParkinson's DiseasePost-stroke+1 more Merz Pharmaceuticals GmbH 184
Large-scale testing (Phase 3)Study completedNCT01994109What this trial is testingEfficacy and Safety Study of MYOBLOC® in the Treatment of Sialorrhea in Adult SubjectsWho this might be right forSialorrhea Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC 187
Post-approval studies (Phase 4)Study completedNCT06319118What this trial is testingA Clinical Study of Dihydroergotine Mesylate Extended-release Tablets for the Treatment of Drooling in Parkinson's Disease.Who this might be right forSalivation in Parkinson's Disease Second Affiliated Hospital of Soochow University 120